SENSE PROTEOMIC
Sense Proteomic is discovers and commercializes autoantibody biomarkers for cancer and autoimmune diseases. It offers Kinome 2.0plus that is used by the pharmaceutical industry to screen kinase leads against human kinases. The company also provides biomarker panels for prostate cancer and lupus.
SENSE PROTEOMIC
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
1996-01-01
Address:
Yarnton, Oxfordshire, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
+44 1865 856 800